跳至主要内容
临床试验/NCT03252067
NCT03252067Unknown1 期

Tear Concentrations and Pharmacokinetics of Azithromycin Following Topical Administration of a Single Dose of Azithromycin Eyedrops in Healthy Volunteers

Beijing Tongren Hospital1 个研究点 分布在 1 个国家目标入组 42 人开始时间: 2017年8月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
发起方
入组人数
42
试验地点
1
主要终点
the maximum concentration (Cmax)

研究概览

简要总结

To evaluate azithromycin tear concentrations after one drop of azithromycin eyedrops (2.5ml/25mg) in healthy volunteers.

详细描述

In this randomized, open, single-center study, 42 healthy volunteers will receive one drop of azithromycin into each eye. Azithromycin tear concentrations will be measured by LC-MS/MS at seven time points for 24 hours. Tolerability is evaluated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 45 years old, male or female;
  • BMI in the range of 19 to 24;
  • eyes corrected visual acuity should be ≥ 1.0, intraocular pressure, slit lamp and fundus examination were normal, tear secretion function is normal;
  • Good compliance and voluntarily signed consent.

排除标准

  • Have eye disease or systemic disease;
  • physical examination, laboratory tests, ECG and chest X-ray examination abnormalities and has clinical significance;
  • HBsAg, anti-HCV, anti-HIV and TPPA positive;
  • those who used eye drops two weeks before the test and who used any dosage form of azithromycin;
  • known to azithromycin or macrolide-related varieties of allergies or serious adverse reactions;
  • need to wear contact lenses during the test;
  • history of internal surgery or laser surgery history;
  • participated in other drug clinical trials in the past three months;
  • pregnant women and lactating women, or in the growth period without taking effective contraceptive measures, menstrual period women;
  • mental illness or alcohol, history of drug abuse or inability to collaborate;
  • Any other circumstances that the investigators consider are unfit to participate in this study.

研究组 & 干预措施

azithromycin eyedrop

Experimental

Each of the subjects' eyes will receive single dose of azithromycin eyedrops and then attribute the time for tear sampling at seven time points up to 24 hours.

干预措施: azithromycin eyedrop (Drug)

结局指标

主要结局

the maximum concentration (Cmax)

时间窗: The tear samples are taken at 7 time points after administration,including 10 minutes,half hour,2 hours,4 hours,8 hours,12 hours and 24hours.

The tear samples are taken at 7 time points after administration up to 24 hours.The Cmax is calculated at the average concentration of each point.

area under the curve (AUC)

时间窗: The tear samples are taken at 7 time points after administration,including 10 minutes,half hour,2 hours,4 hours,8 hours,12 hours and 24hours.

The tear samples are taken at 7 time points after administration up to 24 hours.The AUC is calculated at the average concentration of each point.

次要结局

  • AEs(24 hours)

研究者

发起方
Beijing Tongren Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiuli Zhao

Prof.

Beijing Tongren Hospital

研究点 (1)

Loading locations...

相似试验